Sisir Koppaka1, Irina Shklyar2, Seward B Rutkove2, Basil T Darras3, Brian W Anthony1, Craig M Zaidman4, Jim S Wu5. 1. Laboratory for Manufacturing and Productivity, Massachusetts Institute of Technology, Cambridge, Massachusetts USA, Medical Electronic Device Realization Center, Massachusetts Institute of Technology, Cambridge, Massachusetts USA. 2. Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts USA. 3. Department of Neurology, Boston Children's Hospital, Boston, Massachusetts USA. 4. Departments of Neurology and Pediatrics, Washington University, St Louis Missouri USA. 5. Department of Radiology, Beth Israel Deaconess Medical Center, Boston, Massachusetts USA jswu@bidmc.harvard.edu.
Abstract
OBJECTIVES: The purpose of this study was to investigate the ability of quantitative ultrasound (US) using edge detection analysis to assess patients with Duchenne muscular dystrophy (DMD). METHODS: After Institutional Review Board approval, US examinations with fixed technical parameters were performed unilaterally in 6 muscles (biceps, deltoid, wrist flexors, quadriceps, medial gastrocnemius, and tibialis anterior) in 19 boys with DMD and 21 age-matched control participants. The muscles of interest were outlined by a tracing tool, and the upper third of the muscle was used for analysis. Edge detection values for each muscle were quantified by the Canny edge detection algorithm and then normalized to the number of edge pixels in the muscle region. The edge detection values were extracted at multiple sensitivity thresholds (0.01-0.99) to determine the optimal threshold for distinguishing DMD from normal. Area under the receiver operating curve values were generated for each muscle and averaged across the 6 muscles. RESULTS: The average age in the DMD group was 8.8 years (range, 3.0-14.3 years), and the average age in the control group was 8.7 years (range, 3.4-13.5 years). For edge detection, a Canny threshold of 0.05 provided the best discrimination between DMD and normal (area under the curve, 0.96; 95% confidence interval, 0.84-1.00). According to a Mann-Whitney test, edge detection values were significantly different between DMD and controls (P < .0001). CONCLUSIONS: Quantitative US imaging using edge detection can distinguish patients with DMD from healthy controls at low Canny thresholds, at which discrimination of small structures is best. Edge detection by itself or in combination with other tests can potentially serve as a useful biomarker of disease progression and effectiveness of therapy in muscle disorders.
OBJECTIVES: The purpose of this study was to investigate the ability of quantitative ultrasound (US) using edge detection analysis to assess patients with Duchenne muscular dystrophy (DMD). METHODS: After Institutional Review Board approval, US examinations with fixed technical parameters were performed unilaterally in 6 muscles (biceps, deltoid, wrist flexors, quadriceps, medial gastrocnemius, and tibialis anterior) in 19 boys with DMD and 21 age-matched control participants. The muscles of interest were outlined by a tracing tool, and the upper third of the muscle was used for analysis. Edge detection values for each muscle were quantified by the Canny edge detection algorithm and then normalized to the number of edge pixels in the muscle region. The edge detection values were extracted at multiple sensitivity thresholds (0.01-0.99) to determine the optimal threshold for distinguishing DMD from normal. Area under the receiver operating curve values were generated for each muscle and averaged across the 6 muscles. RESULTS: The average age in the DMD group was 8.8 years (range, 3.0-14.3 years), and the average age in the control group was 8.7 years (range, 3.4-13.5 years). For edge detection, a Canny threshold of 0.05 provided the best discrimination between DMD and normal (area under the curve, 0.96; 95% confidence interval, 0.84-1.00). According to a Mann-Whitney test, edge detection values were significantly different between DMD and controls (P < .0001). CONCLUSIONS: Quantitative US imaging using edge detection can distinguish patients with DMD from healthy controls at low Canny thresholds, at which discrimination of small structures is best. Edge detection by itself or in combination with other tests can potentially serve as a useful biomarker of disease progression and effectiveness of therapy in muscle disorders.
Authors: S A E Peters; H M den Ruijter; M K Palmer; D E Grobbee; J R Crouse; D H O'Leary; G W Evans; J S Raichlen; L Lind; M L Bots Journal: J Intern Med Date: 2011-08-11 Impact factor: 8.989
Authors: K J Bhansing; E P Hoppenreijs; A J Janssen; A van Royen-Kerkhof; M W Nijhuis-Van der Sanden; P L C M van Riel; S Pillen Journal: Scand J Rheumatol Date: 2014-04-11 Impact factor: 3.641
Authors: Craig M Zaidman; Anne M Connolly; Elizabeth C Malkus; Julaine M Florence; Alan Pestronk Journal: Neuromuscul Disord Date: 2010-12 Impact factor: 4.296
Authors: Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin Journal: Lancet Neurol Date: 2009-11-27 Impact factor: 44.182
Authors: Craig M McDonald; Erik K Henricson; Jay J Han; R Ted Abresch; Alina Nicorici; Gary L Elfring; Leone Atkinson; Allen Reha; Samit Hirawat; Langdon L Miller Journal: Muscle Nerve Date: 2010-04 Impact factor: 3.217
Authors: Kush Kapur; Benjamin Sanchez; Adam Pacheck; Basil Darras; Seward B Rutkove; Rajesh Selukar Journal: IEEE Trans Biomed Eng Date: 2018-11-01 Impact factor: 4.538
Authors: Karlien Mul; Corinne G C Horlings; Sanne C C Vincenten; Nicol C Voermans; Baziel G M van Engelen; Nens van Alfen Journal: J Neurol Date: 2018-09-06 Impact factor: 4.849
Authors: Cesar Calvo-Lobo; Ana Isabel Useros-Olmo; Jaime Almazán-Polo; Miriam Martín-Sevilla; Carlos Romero-Morales; Irene Sanz-Corbalán; David Rodríguez-Sanz; Daniel López-López Journal: Int J Environ Res Public Health Date: 2018-11-11 Impact factor: 3.390